WebCalypso Biotech is an innovative biopharmaceutical company based in Geneva, Switzerland and founded in 2013 as a spin-off from Merck Serono, a global leader in auto-immune diseases and biologics. Calypso Biotech was initially financed through a 2.5 million euro seed-fund managed by MS Ventures. A highly experienced management team with … WebCalypso Biotech BV is a private biotechnology company leveraging its unique knowledge of IL-15 biology into the development of medical breakthroughs. Calypso Biotech was established as a spin-off by the healthcare business of Merck, founded by Alain Vicari,

Company Calypso Biotech News, Employees and Funding …

WebFiona is a Senior Director, Venture Investments, Johnson & Johnson Development Corporation (JJDC) and sits on the Boards of Calypso Biotech BV, Pulmocide & Mestag Therapeutics. Prior to joining JJDC, Fiona served as a Director at Inkef Capital. WebAGC Biologics A/S and Calypso Biotech BV Announce Agreement for Process Development and cGMP Manufacture of CALY-002. ... Calypso Biotech is an … how to make gumpaste eucalyptus

Dose Escalation Study to Evaluate an Experimental New …

WebFeb 20, 2024 · Calypso Biotech BV (Amsterdam/Geneva), a spin-out of Merck-Serono, which became company in residence at JLABS in Beerse, Belgium, said it will use the proceeds to push its anti-interleukin-15 (IL … WebFeb 21, 2024 · Calypso Biotech BV is a private biotechnology company focused on the research and development of novel biologics to address unmet medical need in immunological diseases, especially gastrointestinal indications. Calypso Biotech was established in 2013 as a spin-off by the healthcare business of Merck founded by Alain … WebCalypso Biotech is an innovative biopharmaceutical company based in Geneva, Switzerland and founded in 2013 as a spin-off from Merck Serono, a global leader in … msn official news